Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Aug 20, 2025
Open Peer Review Period: Aug 20, 2025 - Oct 15, 2025
Date Accepted: Dec 12, 2025
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Effect of Du-Moxibustion Combined With Spine-Pinching Therapy on Cognitive Frailty in Older Adults With Prefrailty: Protocol for a Randomized Controlled Trial

Liu S, Qi M, Ye Z, Xu Y, Yang X

Effect of Du-Moxibustion Combined With Spine-Pinching Therapy on Cognitive Frailty in Older Adults With Prefrailty: Protocol for a Randomized Controlled Trial

JMIR Res Protoc 2026;15:e82683

DOI: 10.2196/82683

PMID: 41666308

PMCID: 12890076

Effect of Du-moxibustion Combined with Spine-pinching Therapy on Cognitive Frailty in Older Adults with Prefrailty: A Randomized Controlled Trial Protocol

  • Suzhen Liu; 
  • Mengxia Qi; 
  • Ziqiu Ye; 
  • Yu Xu; 
  • Xiangying Yang

ABSTRACT

Background:

Cognitive frailty, characterized by the coexistence of mild cognitive impairment (MCI) and physical frailty in the absence of dementia or other neurodegenerative diseases, is a significant risk factor for dementia and functional decline in older adults. Although Du-moxibustion has shown potential benefits in improving cognitive frailty, the effect of spine-pinching therapy remains underexplored.

Objective:

This study aims to evaluate, for the first time, the efficacy and safety of Du-moxibustion combined with spine-pinching therapy in older adults with prefrailty and cognitive frailty.

Methods:

This is a prospective, single-center, randomized, single-blind, four-arm parallel controlled trial. A total of 160 older adults with prefrailty and cognitive frailty will be recruited and randomly assigned to one of four groups: routine care group, Du-moxibustion group, spine-pinching group, or combined intervention group. The intervention will last for 8 weeks. The primary outcomes are changes in Montreal Cognitive Assessment (MoCA) scores and Fried frailty phenotype scores. Secondary outcomes include Barthel Index (activities of daily living), Geriatric Depression Scale-15 (GDS-15), Short Form Health Survey (SF-36), global frailty status, and Traditional Chinese Medicine (TCM) syndrome scores. Outcome assessments will be conducted at baseline (week 0), mid-intervention (week 6), post-intervention (week 8), and follow-up (week 12).

Results:

Recruitment began in March 2026 and ended in June 2027 ( recruitment and intervention ). Data collection will end in October 2027 and results are expected in early 2028.

Conclusions:

This study is expected to provide high-quality evidence for the clinical efficacy of Du-moxibustion combined with spine-pinching therapy in managing cognitive frailty and contribute to the integration of Traditional Chinese Medicine external therapies in the promotion of healthy aging. Although the single-blind design may introduce expectancy bias, strict randomization procedures and standardized interventions will enhance the reliability and scientific rigor of the results. Clinical Trial: International Traditional Medicine Clinical Trial Registry ITMCTR2025001589 https://itmctr.ccebtcm.org.cn/


 Citation

Please cite as:

Liu S, Qi M, Ye Z, Xu Y, Yang X

Effect of Du-Moxibustion Combined With Spine-Pinching Therapy on Cognitive Frailty in Older Adults With Prefrailty: Protocol for a Randomized Controlled Trial

JMIR Res Protoc 2026;15:e82683

DOI: 10.2196/82683

PMID: 41666308

PMCID: 12890076

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.